Evidence map›Paper›PMID 38089163›Full record

ArticleArchives of medical sciences. Atherosclerotic diseases2023

The choice of conduits in coronary artery bypass surgery.

Ioannis Panagiotopoulos, Vasileios Leivaditis, Assaf Sawafta, Anastasia Katinioti, Konstantinos Tasios, Vasiliki Garantzioti, Korina-Thomais Stathi, Andreas Antzoulas, Christos Pitros, Charalampos Kaplanis and 2 more

Open access · diamondAbstract read
In one paragraph

Article in Archives of medical sciences. Atherosclerotic diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 3 countries.

Ioannis PanagiotopoulosDepartment of Cardiothoracic Surgery, General University Hospital of Patras, Patras, Greece.
Vasileios LeivaditisDepartment of Cardiothoracic and Vascular Surgery, Westpfalz-Klinikum, Kaiserslautern, Germany.
Assaf SawaftaDepartment of Cardiology, University Hospital of Larissa, Larissa, Greece.
Anastasia KatiniotiCardiology Department, Elpis General Hospital, Athens, Greece.
Konstantinos TasiosDepartment of Surgery, General University Hospital of Patras, Patras, Greece.
Vasiliki GarantziotiDepartment of Surgery, General University Hospital of Patras, Patras, Greece.
Korina-Thomais StathiUniversity of Medicine and Pharmacy "Carol Davila", Bucharest, Romania.
Andreas AntzoulasDepartment of Surgery, General University Hospital of Patras, Patras, Greece.
Christos PitrosDepartment of Vascular Surgery, General University Hospital of Patras, Patras, Greece.
Charalampos KaplanisDepartment of Surgery, General University Hospital of Patras, Patras, Greece.
Georgios-Ioannis VerrasDepartment of Surgery, General University Hospital of Patras, Patras, Greece.
Francesk MulitaDepartment of Surgery, General University Hospital of Patras, Patras, Greece.
General University Hospital of Patras · GRCarol Davila University of Medicine and Pharmacy · ROGeneral Hospital of Athens Elpis · GRUniversity Hospital of Larissa · GRWestpfalz Klinikum · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Choosing appropriate bypass conduits is important in the consideration of long-term outcomes after surgical revascularization. When deciding on a grafting strategy, attention should be given to technical, anatomic, and angiographic determinants of conduit properties, as well as the clinical characteristics of the patient. The aim of the study was to present a current review of available choices of conduits in coronary artery bypass surgery. To date, only 4 conduits have proven to be effective: the saphenous vein (SVG), the internal mammary arteries (IMAs), the radial artery (RA), and the right gastroepiploic artery (RGEA). The IMA has unique biological properties that confer protection to intimal growth and atherosclerotic plaque formation, making it the conduit of choice for coronary artery bypass grafting. SVG exhibits a lower patency rate than those of IMAs. The RGEA allows revascularization of the inferior wall but is less commonly used, given that it is more prone to spasms.

Indexed as

arterial graftsconduitsinternal mammary arteryradial artery

Identifiers

PMID38089163
PMCPMC10711784
OpenAlexW4387366684

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.